Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
19%
OVERLAP
BY WEIGHT
23
# OF OVERLAPPING
HOLDINGS
WELS.DE
86
HOLDINGS
27%
ALSO IN ESIH.L
ESIH.L
49
HOLDINGS
66%
ALSO IN WELS.DE
SECTOR DRIFT (WELS.DE minus ESIH.L)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WELS.DE |
Weight in ESIH.L |
Overlap | |
|---|---|---|---|---|
| ASTRAZENECA PLC | 4.6% | 15.5% | 4.6% | |
| NOVARTIS AG | 4.1% | 15.4% | 4.1% | |
| NOVO NORDISK A/S-B | 2.3% | 8.0% | 2.3% | |
| GSK PLC | 1.5% | 5.7% | 1.5% | |
| SANOFI-AVENTIS | 1.5% | 5.3% | 1.5% | |
WELS.DE Overweight Relative to ESIH.L
| ELI LILLY & CO | 12.0% | |
| ABBVIE INC | 6.9% | |
| UNITEDHEALTH GROUP INC | 6.2% | |
| MERCK & CO. INC. | 4.8% | |
| AMGEN INC | 3.1% | |
| THERMO FISHER SCIENTIFIC INC | 3.1% | |
| GILEAD SCIENCES INC | 2.7% | |
| INTUITIVE SURGICAL INC | 2.6% | |
| ABBOTT LABORATORIES | 2.3% | |
| BRISTOL-MYERS SQUIBB CO | 2.2% |
WELS.DE Underweight Relative to ESIH.L
| NOVARTIS AG | -11.2% | |
| ASTRAZENECA PLC | -10.9% | |
| NOVO NORDISK A/S-B | -5.7% | |
| GSK PLC | -4.2% | |
| SANOFI-AVENTIS | -3.9% | |
| ESSILOR INTERNATIONAL | -2.5% | |
| BAYER AG | -2.4% | |
| HALEON PLC | -2.2% | |
| ARGEN-X SE | -2.0% | |
| SANDOZ GROUP AG | -2.0% |